Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Perspective Therapeutics (AMEX:CATX) through any online brokerage.
Other companies in Perspective Therapeutics’s space includes: Kalaris Therapeutics Inc (NASDAQ:KLRS), Innate Pharma SA (NASDAQ:IPHA), Humacyte Inc (NASDAQ:HUMA), Burning Rock Biotech Ltd (NASDAQ:BNR) and Inovio Pharmaceuticals Inc (NASDAQ:INO).
Perspective Therapeutics has a consensus price target of $10.33.
The stock price for Perspective Therapeutics (AMEX: CATX) is $2.8 last updated December 16, 2025 at 7:58 PM EST.
There are no upcoming dividends for Perspective Therapeutics.
Perspective Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Perspective Therapeutics.
Perspective Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.